REFERENCES
- Wideman P., Heiman K. (1992) Curr. opinion in ophthalmology, 3 357–365.
- Kirchhof B. et al. (1989) Pathogenesis of proliferative vitreoretinopathy. In Straub W/ed/Proliferative vitreoretinopathy. Genetics of glaucoma. Dev. Ophthalmol. Basel Karger, 16 1–53.
- Grizard W.S., Hilton G.F., Hammer M.E. et al. (1994) Craefes Arch. Clin. Exp. Ophthlmol., 232 1–7.
- Weller M. et al. (1990) Int. Ophthalmol., 14 105.
- Toti P. et al. (1994) Doc. Ophthalmol., 88 105–112.
- Kalvatchev Z., Draganov P., Gancheva A., Sayej M. (2003) Biotechnol. & Biotrchnol. Eq., 17 (2), 146–150.
- Machemer R. et al. (1975) Am. J. Ophthalmol. 80 1 1–23.
- Machemer R., Aaberg T., Frecman H. et al. (1991) J. of ophthalmology, 112 159.
- Auer G., (1990) DNA: A clinical parameter. Publ. by Becton Dicinson immunocytometry systems, Erembodegem, Belgium.
- Little B. C. et al. (1991) Eye, 5 56–62.
- Algvere P. V. et al. (1999) Arch. Clin. Exp. Ophthalmol., 2 137–144.
- Cousisns S.W., Rubsamen P.E. (1994) Comparsion of flowcytometry with the surgeon regarding ability to predict the ultimate success of surgery for proliferative vitreoretinopathy. Arch. of ophthalmology, 112.